Literature DB >> 26020031

Clinical Practice Guidelines for Hepatocellular Carcinoma Differ between Japan, United States, and Europe.

.   

Abstract

Entities:  

Year:  2015        PMID： 26020031      PMCID： PMC4439783          DOI： 10.1159/000367730

Source DB:  PubMed          Journal:  Liver Cancer        ISSN： 1664-5553            Impact factor:   11.740


× No keyword cloud information.
  22 in total

1.  Radiofrequency ablation of hepatocellular carcinoma in patients with decompensated cirrhosis: evaluation of therapeutic efficacy and safety.

Authors:  Young Kon Kim; Chong Soo Kim; Gyong Ho Chung; Young Min Han; Sang Yong Lee; Gong Yong Jin; Jeong Min Lee
Journal:  AJR Am J Roentgenol       Date:  2006-05       Impact factor: 3.959

Review 2.  Liver transplantation for hepatocellular carcinoma.

Authors:  See Ching Chan
Journal:  Liver Cancer       Date:  2013-08       Impact factor: 11.740

3.  Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH-HCC Guidelines).

Authors:  Norihiro Kokudo; Kiyoshi Hasegawa; Masaaki Akahane; Hiroshi Igaki; Namiki Izumi; Takafumi Ichida; Shinji Uemoto; Shuichi Kaneko; Seiji Kawasaki; Yonson Ku; Masatoshi Kudo; Shoji Kubo; Tadatoshi Takayama; Ryosuke Tateishi; Takashi Fukuda; Osamu Matsui; Yutaka Matsuyama; Takamichi Murakami; Shigeki Arii; Masatoshi Okazaki; Masatoshi Makuuchi
Journal:  Hepatol Res       Date:  2015-01       Impact factor: 4.288

4.  Clinical efficacy of non-transplant therapies in patients with hepatocellular carcinoma with Child-Pugh C liver cirrhosis.

Authors:  Hiroki Nishikawa; Ryuichi Kita; Toru Kimura; Yoshiaki Ohara; Haruhiko Takeda; Azusa Sakamoto; Sumio Saito; Norihiro Nishijima; Akihiro Nasu; Hideyuki Komekado; Yukio Osaki
Journal:  Anticancer Res       Date:  2014-06       Impact factor: 2.480

5.  Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.

Authors:  Masatoshi Kudo; Namiki Izumi; Norihiro Kokudo; Osamu Matsui; Michiie Sakamoto; Osamu Nakashima; Masamichi Kojiro; Masatoshi Makuuchi
Journal:  Dig Dis       Date:  2011-08-09       Impact factor: 2.404

Review 6.  Treatment of advanced hepatocellular carcinoma with emphasis on hepatic arterial infusion chemotherapy and molecular targeted therapy.

Authors:  Masatoshi Kudo
Journal:  Liver Cancer       Date:  2012-09       Impact factor: 11.740

Review 7.  Local ablation for hepatocellular carcinoma in taiwan.

Authors:  Shi-Ming Lin
Journal:  Liver Cancer       Date:  2013-04       Impact factor: 11.740

8.  Treatment of hepatocellular carcinoma with Child-Pugh C cirrhosis.

Authors:  Kazuhiro Nouso; Norihiro Kokudo; Masatoshi Tanaka; Ryoko Kuromatsu; Hiroki Nishikawa; Hidenori Toyoda; Naoki Oishi; Kenji Kuwaki; Masashi Kusanaga; Takuki Sakaguchi; Zenichi Morise; Satoshi Kitai; Masatoshi Kudo
Journal:  Oncology       Date:  2014-11-22       Impact factor: 2.935

Review 9.  JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan.

Authors:  Masatoshi Kudo; Osamu Matsui; Namiki Izumi; Hiroko Iijima; Masumi Kadoya; Yasuharu Imai; Takuji Okusaka; Shiro Miyayama; Kaoru Tsuchiya; Kazuomi Ueshima; Atsushi Hiraoka; Masafumi Ikeda; Sadahisa Ogasawara; Tatsuya Yamashita; Tetsuya Minami; Koichiro Yamakado
Journal:  Liver Cancer       Date:  2014-10       Impact factor: 11.740

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425
View more
  21 in total

1.  Locoregional Therapy for Hepatocellular Carcinoma.

Authors:  M Kudo
Journal:  Liver Cancer       Date:  2015-06-05       Impact factor: 11.740

2.  Albumin-Bilirubin Grade and Hepatocellular Carcinoma Treatment Algorithm.

Authors:  Masatoshi Kudo
Journal:  Liver Cancer       Date:  2017-03-09       Impact factor: 11.740

3.  Efficacy of radiofrequency ablation of hepatocellular carcinoma prior to liver transplantation and the need for competing-risk analysis.

Authors:  Alessandro Cucchetti; Matteo Serenari
Journal:  Hepatobiliary Surg Nutr       Date:  2018-08       Impact factor: 7.293

4.  Risk of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Who Achieved Sustained Virological Response.

Authors:  M Kudo
Journal:  Liver Cancer       Date:  2016-05-03       Impact factor: 11.740

5.  Heterogeneity and Subclassification of Barcelona Clinic Liver Cancer Stage B.

Authors:  M Kudo
Journal:  Liver Cancer       Date:  2016-03-17       Impact factor: 11.740

6.  Diagnostic Accuracy of PIVKA-II, Alpha-Fetoprotein and a Combination of both in Diagnosis of Hepatocellular Carcinoma in Patients Affected by Chronic HCV Infection.

Authors:  Ivan Gentile; Antonio Riccardo Buonomo; Riccardo Scotto; Emanuela Zappulo; Canio Carriero; Mauro Piccirillo; Francesco Izzo; Marianna Rizzo; Dionigio Cerasuolo; Guglielmo Borgia; Ernesta Cavalcanti
Journal:  In Vivo       Date:  2017 Jul-Aug       Impact factor: 2.155

7.  Ramucirumab for Patients with Intermediate-Stage Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Results from Two Phase 3 Studies (REACH and REACH-2).

Authors:  Masatoshi Kudo; Richard S Finn; Manabu Morimoto; Kun-Ming Rau; Masafumi Ikeda; Chia-Jui Yen; Peter R Galle; Josep M Llovet; Bruno Daniele; Ho Yeong Lim; David W McIlwain; Reigetsu Yoshikawa; Kenichi Nakamura; Kun Liang; Chunxiao Wang; Paolo Abada; Ryan C Widau; Andrew X Zhu
Journal:  Liver Cancer       Date:  2021-07-12       Impact factor: 11.740

8.  Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma: Japanese subgroup analysis of the REACH trial.

Authors:  Masatoshi Kudo; Etsuro Hatano; Shinichi Ohkawa; Hirofumi Fujii; Akihide Masumoto; Junji Furuse; Yoshiyuki Wada; Hiroshi Ishii; Shuntaro Obi; Shuichi Kaneko; Seiji Kawazoe; Osamu Yokosuka; Masafumi Ikeda; Katsuaki Ukai; Sojiro Morita; Akihito Tsuji; Toshihiro Kudo; Mitsuo Shimada; Yukio Osaki; Ryosuke Tateishi; Gen Sugiyama; Paolo Benjamin Abada; Ling Yang; Takuji Okusaka; Andrew Xiuxuan Zhu
Journal:  J Gastroenterol       Date:  2016-08-22       Impact factor: 7.527

9.  Pure hepatocellular carcinoma originates from an ectopic liver nodule located in the pancreas.

Authors:  Marcin Braun; Wojciech Kuncman; Leszek Teresiński; Piotr Kupnicki; Dorota Jesionek-Kupnicka; Radzislaw Kordek
Journal:  Contemp Oncol (Pozn)       Date:  2017-12-30

Review 10.  Portal vein thrombosis in cirrhosis: diagnosis, natural history, and therapeutic challenges.

Authors:  Aikaterini Mantaka; Aikaterini Augoustaki; Elias A Kouroumalis; Dimitrios N Samonakis
Journal:  Ann Gastroenterol       Date:  2018-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.